Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.
暂无分享,去创建一个
A. Evans | R. Weersink | B. Wilson | J. Trachtenberg | M. Haider | A. Bogaards | M. Gertner | A. Scherz | J. Savard | M. Elhilali | S. McCluskey | A. Aprikian | J Trachtenberg | B C Wilson | M R Gertner | S. Appu | S A McCluskey | M Elhilali | C. Yue | R A Weersink | M A Haider | A Bogaards | A Scherz | M. Haider | A Evans | C Yue | S Appu | A Aprikian | J Savard | C. K. Yue | Mostafa M. Elhilali | Brian C. Wilson | Massom A. Haider | Stuart A. McCluskey | Clarence K. K. Yue
[1] Brian C. Wilson,et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. , 2005 .
[2] M S Patterson,et al. In vivo TESTS OF THE CONCEPT OF PHOTODYNAMIC THRESHOLD DOSE IN NORMAL RAT LIVER PHOTOSENSITIZED BY ALUMINUM CHLOROSULPHONATED PHTHALOCYANINE , 1990, Photochemistry and photobiology.
[3] Avigdor Scherz,et al. Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts , 2003, International journal of cancer.
[4] R. Riffenburgh,et al. 20-year outcome of patients with T1-3N0 surgically staged prostate cancer treated with external beam radiation therapy. , 2001, The Journal of urology.
[5] M. Snell,et al. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.
[6] Michal Neeman,et al. Antivascular Treatment of Solid Melanoma Tumors with Bacteriochlorophyll–serine-based Photodynamic Therapy¶ , 2001 .
[7] Stanley B. Brown,et al. The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.
[8] S. Andersson,et al. Photodynamic therapy of localised prostatic cancer , 1990, The Lancet.
[9] Shi-Chung Chang,et al. Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5‐aminolevulinic acid‐induced protoporphyrin IX , 1997, The Prostate.
[10] M Emberton,et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer , 2006, Lasers in surgery and medicine.
[11] Stephen G Bown,et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. , 2002, The Journal of urology.
[12] Daniel Braichotte,et al. Clinical Evaluation of the Cutaneous Phototoxicity of 5,10,15,20‐Tetra (m‐hydroxyphenyl)chlorin , 1998, Photochemistry and photobiology.
[13] A. Zietman,et al. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. , 1994, The Journal of urology.
[14] George Starkschall,et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial , 2003 .
[15] Robert A Weersink,et al. Assessment of Cutaneous Photosensitivity of TOOKAD (WST09) in Preclinical Animal Models and in Patients¶ , 2005, Photochemistry and photobiology.
[16] Jarod C Finlay,et al. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. , 2005, Journal of photochemistry and photobiology. B, Biology.
[17] R W Keck,et al. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. , 2001, The Journal of urology.
[18] Kai Zhang,et al. Techniques for delivery and monitoring of TOOKAD(WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities , 2005, SPIE BiOS.
[19] A. Radu,et al. Evaluation of the Photosensitizer Tookad® for Photodynamic Therapy on the Syrian Golden Hamster Cheek Pouch Model: Light Dose, Drug Dose and Drug–light Interval Effects¶ , 2003, Photochemistry and photobiology.
[20] S B Malkowicz,et al. Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer , 2006, Lasers in surgery and medicine.
[21] J. Trachtenberg,et al. Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. , 2001, The Journal of urology.
[22] Zheng Huang,et al. Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶ , 2002, Photochemistry and photobiology.
[23] Michael J. Zelefsky,et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.
[24] G Naglie,et al. Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer. , 2000, Journal of clinical epidemiology.